Moreover, an inverse correlation trend between disease duration and response rate to rituximab was observed which also did not reach statistical significance.
← all excerpts
Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society.
1
—
—